6 research outputs found

    Highly Sensitive Coherent Anti-Stokes Raman Scattering Imaging of Protein Crystals

    No full text
    Serial crystallography at last generation X-ray synchrotron sources and free electron lasers enabled data collection with micrometer and even submicrometer size crystals, which have resulted in amazing progress in structural biology. However, imaging of small crystals, which although is highly demanded, remains a challenge, especially in the case of membrane protein crystals. Here we describe a new extremely sensitive method of the imaging of protein crystals that is based on coherent anti-Stokes Raman scattering

    3D Silver Dendrites for Single-molecule Imaging by Surface-enhanced Raman Spectroscopy

    No full text
    Discovery of surface-enhanced Raman scattering (SERS) followed by evolution of optical systems and nanoengineering approaches has paved a path to detection of essential organic molecules on solid SERS-active substrates from solutions at concentrations attributed to single-molecule ones, i. e. below 10(-15) M. However, in practical terms confident SERS-imaging of single molecules is still quite a challenge. In present work, we fabricated and comprehensively characterized tightly-packed 3D silver dendrites with prevalent chevron morphology that demonstrated ultrahigh sensitivity as SERS-active substrates resulted in 10(-18) M detection limit. Using these substrates we achieved SERS-imaging of single 5-thio-2-nitrobenzoic acid (TNB) molecule released from the attomolar-concentrated solution of of 5,5 '-dithio-bis-[2-nitrobenzoic acid] (DTNB), which is vital compound for chemical and biomedical analysis. In contrast to generally accepted belief about adsorption of only uniform monomolecular TNB layer on surface of silver nanostructures, we showed formation of a coating constituted by TNB layer and DTNB nanoclusters on the dendrites' surface at 10(-6)-10(-12) M DTNB concentrations confirmed by presence/absence of disulfide bonds signature in the SERS-spectra and by scanning electron microscopy. DTNB concentrations below 10(-14) M resulted in adsorption of TNB molecules in separated spots on the surface of silver nanostructures

    Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells

    No full text
    Abstract Ovarian cancer often develops resistance to conventional therapies, hampering their effectiveness. Here, using ex vivo paired ovarian cancer ascites obtained before and after chemotherapy and in vitro therapy-induced secretomes, we show that molecules secreted by ovarian cancer cells upon therapy promote cisplatin resistance and enhance DNA damage repair in recipient cancer cells. Even a short-term incubation of chemonaive ovarian cancer cells with therapy-induced secretomes induces changes resembling those that are observed in chemoresistant patient-derived tumor cells after long-term therapy. Using integrative omics techniques, we find that both ex vivo and in vitro therapy-induced secretomes are enriched with spliceosomal components, which relocalize from the nucleus to the cytoplasm and subsequently into the extracellular vesicles upon treatment. We demonstrate that these molecules substantially contribute to the phenotypic effects of therapy-induced secretomes. Thus, SNU13 and SYNCRIP spliceosomal proteins promote therapy resistance, while the exogenous U12 and U6atac snRNAs stimulate tumor growth. These findings demonstrate the significance of spliceosomal network perturbation during therapy and further highlight that extracellular signaling might be a key factor contributing to the emergence of ovarian cancer therapy resistance
    corecore